Last reviewed · How we verify
Bupivacaine 0.5% — Competitive Intelligence Brief
marketed
Local anesthetic (amide class)
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
Bupivacaine 0.5% (Bupivacaine 0.5%) — Kasr El Aini Hospital. Bupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bupivacaine 0.5% TARGET | Bupivacaine 0.5% | Kasr El Aini Hospital | marketed | Local anesthetic (amide class) | Voltage-gated sodium channels | |
| Lidocaïne | Lidocaïne | University Hospital, Angers | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Hydrocortisone acetate and lidocaine hydrochloride | Hydrocortisone acetate and lidocaine hydrochloride | Citius Pharmaceuticals, Inc. | marketed | Topical corticosteroid and local anesthetic combination | Glucocorticoid receptor (hydrocortisone); voltage-gated sodium channels (lidocaine) | |
| Lidocaine alone | Lidocaine alone | TriHealth Inc. | marketed | Local anesthetic | Voltage-gated sodium channels | |
| lidocaine and sufentanil | lidocaine and sufentanil | RenJi Hospital | marketed | Local anesthetic and opioid analgesic combination | Voltage-gated sodium channels (lidocaine); mu opioid receptor (sufentanil) | |
| Low-Dose Lidocaine | Low-Dose Lidocaine | The Methodist Hospital Research Institute | marketed | Local anesthetic / sodium channel blocker | Voltage-gated sodium channels | |
| Naropeine (Ropivacaine) | Naropeine (Ropivacaine) | Nantes University Hospital | marketed | Local anesthetic (amide) | Voltage-gated sodium channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (amide class) class)
- Ain Shams University · 2 drugs in this class
- Başakşehir Çam & Sakura City Hospital · 2 drugs in this class
- TriHealth Inc. · 2 drugs in this class
- Centre of Postgraduate Medical Education · 2 drugs in this class
- Bozyaka Training and Research Hospital · 2 drugs in this class
- Complejo Hospitalario Universitario de Granada · 1 drug in this class
- Clinique Saint-Jean, Bruxelles · 1 drug in this class
- Hospital Clínico Universitario de Valencia · 1 drug in this class
- Fundacion Clinica Valle del Lili · 1 drug in this class
- Federal University of Minas Gerais · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bupivacaine 0.5% CI watch — RSS
- Bupivacaine 0.5% CI watch — Atom
- Bupivacaine 0.5% CI watch — JSON
- Bupivacaine 0.5% alone — RSS
- Whole Local anesthetic (amide class) class — RSS
Cite this brief
Drug Landscape (2026). Bupivacaine 0.5% — Competitive Intelligence Brief. https://druglandscape.com/ci/bupivacaine-0-5. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab